.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
QuintilesIMS
Colorcon
Harvard Business School
Fuji
Cerilliant
Farmers Insurance
Johnson and Johnson
Cipla
Chubb

Generated: June 22, 2017

DrugPatentWatch Database Preview

GRIFULVIN V Drug Profile

« Back to Dashboard

What is the patent landscape for Grifulvin V, and what generic Grifulvin V alternatives are available?

Grifulvin V is a drug marketed by J And J, Johnson And Johnson, and Valeant Luxembourg. and is included in four NDAs.

The generic ingredient in GRIFULVIN V is griseofulvin, microsize. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the griseofulvin, microsize profile page.

Summary for Tradename: GRIFULVIN V

Patents:0
Applicants:3
NDAs:4
Suppliers / Packagers: see list1
Bulk Api Vendors: see list77
Clinical Trials: see list2
Patent Applications: see list4,549
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GRIFULVIN V at DailyMed

Pharmacology for Tradename: GRIFULVIN V

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J
GRIFULVIN V
griseofulvin, microcrystalline
TABLET;ORAL060618-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Valeant Luxembourg
GRIFULVIN V
griseofulvin, microsize
TABLET;ORAL062279-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Johnson And Johnson
GRIFULVIN V
griseofulvin, microcrystalline
SUSPENSION;ORAL050448-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Valeant Luxembourg
GRIFULVIN V
griseofulvin, microsize
SUSPENSION;ORAL062483-001Jan 26, 1984DISCNNoNo► Subscribe► Subscribe
J And J
GRIFULVIN V
griseofulvin, microcrystalline
TABLET;ORAL060618-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Citi
US Department of Justice
Healthtrust
Fish and Richardson
Baxter
Cerilliant
Merck
Colorcon
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot